.svg){kind=small}
Apr-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
C Minor has shown a consistent presence in the Ontario market, particularly in the Capsules category, where it maintained a steady ranking, hovering around the 11th to 12th position from January to April 2025. This stability suggests a solid consumer base and reliable product performance in this category. However, there was a noticeable drop in sales from January to February, followed by a recovery in March, indicating some fluctuation in consumer demand or market conditions. Such movements could hint at seasonal trends or shifts in consumer preferences that might be worth exploring further for strategic adjustments.
In contrast, C Minor's performance in the Oil category in Ontario showed less stability, with rankings in January and February but absent from the top 30 in March and April. This decline could be viewed as a negative indicator, suggesting increased competition or a decrease in consumer interest in their oil products. The absence from the rankings in the latter months of the observed period could also reflect a strategic shift or potential supply chain issues. Understanding these dynamics might be crucial for stakeholders looking to optimize product offerings and regain market position in this category.
Competitive Landscape
In the competitive landscape of the Capsules category in Ontario, C Minor has shown a fluctuating performance in terms of rank and sales over the first four months of 2025. Starting at 12th place in January, C Minor maintained its position in February, improved to 11th in March, and then slipped back to 12th in April. This movement indicates a competitive struggle, particularly against brands like Stigma Grow, which consistently held the 8th and 9th positions, showcasing a more stable market presence. Meanwhile, Pennies and Frank have also been notable competitors, with Frank overtaking C Minor in April by climbing to 11th place. Despite these challenges, C Minor's sales saw a notable increase in March, suggesting potential for growth if they can capitalize on market opportunities and address competitive pressures effectively.
Notable Products
In April 2025, CBD Fast Acting 50 Max Softgels 30-Pack (1500mg CBD) maintained its position as the top-selling product for C Minor, with sales reaching 699 units. Following closely, CBD Isolate 100 Max 3000 Oil (30ml) held steady in the second rank, showing consistent performance from the previous month. CBD 50 Max 3000 Oil Drops (60ml) remained in third place, experiencing a decline in sales compared to earlier months. Fast Acting Max Softgels 30-Pack (300mg) improved its rank to fourth, recovering from a drop in February. CBG:CBD 1:2 Max 2250 Ultra Formula Oil (30ml) rounded out the top five, despite a significant decrease in sales.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
